Search

everythinglearnresearchcommunity

for

Search:↓

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

The gp130 receptor helps in tissue regeneration and disease progression, and manipulating it could improve healing and prevent disease.

Th22 cells are essential for Tβ15-induced hair growth in mice.

LONRF1 is important for oxidative damage response and tissue remodeling during wound healing.

T cells affect skin cell genes in inflammatory diseases, and therapy can normalize these changes.

HuR is essential for Treg function and preventing autoimmunity.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Keratin 17 is important for hair and nail structure and affects pachyonychia congenita symptoms.

IL-1 receptor absence in mice leads to skin cysts and changes in immune response after UVB exposure.

Certain genetic variations in IL-16 may increase the risk of alopecia areata.

IL-15 helps maintain hair growth and protects the immune status of hair follicles.

Certain IL-18 gene variations may increase the risk of alopecia areata.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

Regulatory T cells help prevent autoimmunity and have potential for treating autoimmune diseases.

The L412F variant of TLR3 is linked to skin infections, more viral infections, and autoimmune issues.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

A substance called poly(I:C) increases a protein called carbonic anhydrase II in skin cells, which might help with skin defense and healing.

A protein called lfTSLP is important in causing allergic and other skin diseases and could be a target for treatment.

REV7 is crucial for genome stability and cancer treatment, making it a potential target for therapy.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

Type XVII collagen helps control skin cell growth and could be a target for anti-aging treatments.

Tissue environment greatly affects the unique epigenetic makeup of regulatory T cells, which could impact autoimmune disease treatment.

A protein called PCBP2 controls the production of a hair growth protein by interacting with its genetic message and is linked to hair loss when this control is disrupted.

IL-27 may help prevent hair loss by creating immune-suppressing cells.

Only one of the two K16 genes on chromosome 17 makes a functional protein for keratin filaments.